S&S Health (“S&S”), one of the leading providers of administration and technology solutions to self-insured employers, TPAs, and health plans, announced that it has received a majority investment from Lovell Minnick Partners (“LMP”) to support its next chapter of growth. Terms of the transaction were not disclosed.
Founded in 1994, S&S partners with brokers, program managers, carriers, and other third-party administrators to offer comprehensive healthcare services and coverage. S&S’ proprietary claims adjudication platform enables the Company to support any plan design, level of complexity and account structure to offer cost-effective, tailored solutions for employers, specifically within the small and mid-sized businesses segment. In addition to benefit plan administration, the Company provides employers with provider network access and a marketplace of solutions for wellness and cost containment strategies.
“The partnership with LMP represents an exciting chapter in our Company’s history. We are confident that LMP’s extensive experience and resources will empower us to provide even more cutting-edge healthcare solutions to the market and make a positive impact on benefit administration and cost containment strategies,” said Vincent Esposito, CEO of S&S. “Our dedication to delivering exceptional healthcare services remains unchanged, and with LMP as our new partner, we are poised to elevate our client experience to new heights and remain a reliable partner our clients can count on.”
“We have a strong history of forming successful partnerships with technology-driven companies led by dynamic management teams known for their client-centric approach and a track record of organic growth,” said Brad Armstrong, Partner at LMP. “We believe that with our resources and strategic guidance, S&S will continue to be a leader in the benefits marketplace and provide their clients with the highest quality of service.”
The transaction is expected to close in the fourth quarter of 2023, subject to customary regulatory reviews and approvals.